By Caroline Valetkevitch (Reuters) - U.S. stocks ended down more than 1% on Tuesday after President Donald Trump said he was calling off negotiations with Democratic lawmakers on...
By Herbert Lash (Reuters) - Wall Street's main indexes fell sharply on Wednesday after data showing a cooling of U.S. business activity and the stalemate in Congress over more...
By Sinéad Carew (Reuters) - Investors eyeing a turnaround in the U.S. economy are piling into U.S. bank stocks even as some caution that positive stress test results and an...
IntelGenx Corp. (OTC:IGXT) announced that it has resubmitted its new drug application (“NDA”) for Rizaport VersaFilm for the treatment of acute migraines to the FDA. ...
IntelGenx Technologies Corp. (OTC:IGXT) announced that the FDA has accepted the resubmission of 505(b)(2) new drug application (NDA) for Rizaport oral soluble film 10 mg, which...
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Sell | Buy | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 153.12 | 153.58 | 147.06 | +4.15 | +2.79% | 40.51M | NASDAQ | |||
| 181.41 | 183.80 | 169.93 | +8.19 | +4.73% | 209.97M | NASDAQ | |||
| 145.43 | 146.61 | 141.32 | +1.14 | +0.79% | 76.29M | NASDAQ | |||
| 1.42 | 1.88 | 0.65 | +0.90 | +171.77% | 139.76M | NASDAQ | |||
| 105.15 | 106.24 | 101.24 | +2.02 | +1.96% | 75.13M | NASDAQ | |||
| 84.64 | 85.48 | 77.88 | +9.49 | +12.63% | 151.28M | NASDAQ | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 29.07 | 29.43 | 27.68 | +0.81 | +2.87% | 62.58M | NASDAQ | |||
| 252.75 | 255.18 | 245.47 | +4.94 | +1.99% | 29.71M | NASDAQ | |||
| 8.13 | 8.19 | 7.76 | +0.24 | +3.04% | 6.21M | NYSE | |||
| 209.43 | 211.92 | 196.11 | +14.06 | +7.20% | 65.31M | NASDAQ | |||
| 12.10 | 12.32 | 11.59 | +0.03 | +0.25% | 64.58M | NYSE | |||
| 100.43 | 101.19 | 97.58 | +1.59 | +1.61% | 32.80M | NASDAQ | |||
| 61.33 | 61.58 | 60.62 | +0.01 | +0.02% | 12.47M | NYSE | |||
| 49.96 | 50.01 | 49.15 | +0.26 | +0.52% | 3.51K | OTC Markets |